Researchers are excited about the medication , a innovative dual agonist showing promising results in initial trials for weight loss . It functions by targeting two hormones : GLP-1 and GIP, which , when https://asiyahvda195213.blogoxo.com/41158442/a-new-prospect-for-body-loss